Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) — The “Global Advanced Balloon Catheter Market: Analysis and Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offering. The global advanced balloon catheter market is witnessing a moderate decline in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $2,523.9 million in FY2019, and it is expected to grow at a CAGR of 6.25% during the forecast period, 2021-2030. Presently, more than 70 companies are operating in this market, including already existing and emerging medical device companies.Owing to the COVID-19 pandemic, the global elective surgeries were shutdown, which, in turn, caused the decline of the global advanced balloon catheter market in 2020. However, the impact of the pandemic is anticipated to be short-term, and with the resumption of elective procedures, the global advanced balloon catheter market is projected to recover from 2021.Our healthcare experts are continuously analyzing the impact of the industrial and regulatory decisions on the global advanced balloon catheter market. The market is driven by certain factors, increasing prevalence of cardiovascular and peripheral artery diseases, increasing demand for minimally invasive surgeries, advancements in the balloon catheters, and favorable reimbursement landscape in developed economies.The market is favored by the development of novel drug-coated balloon catheter and multipurpose balloon catheter.Within the research report, the market is segmented based on product type, component, application, patient age, end-user, and regional analysis. Each of these segments covers the market’s snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.Key Questions Answered in this Report: * How has the COVID-19 pandemic impacted the global advanced balloon catheter market? * What is the adoption rate of the balloon catheters in peripheral artery disease (PAD) and coronary artery disease (CAD) across various regions? * What is the reimbursement landscape for the balloon catheters across various regions? * How does the regulatory landscape for the balloon catheters impact the overall global advanced balloon catheter market? * Who are the key players in the global advanced balloon catheters and their respective market share? * What are the key strategies employed by the companies for entering the market between 2016-June 2020? * What is the patent landscape for the global advanced balloon catheter market? Who are the major market players that have filed for patents between January 2017- August 2020? * How will the entry of products that are in the pipeline till mid-September 2020 impact the global advanced balloon catheter market during the forecast period 2021-2030? * What are the various types of balloon catheters available in the global advanced balloon catheter market? What is their market share in 2019 and 2030, respectively? * Which type of balloon catheter is anticipated to witness the growth with the highest compound annual growth rate (CAGR) during the forecast period 2021-2030? * What are the emerging applications for the balloon catheters? * What are the various components of balloon catheters? Which type of balloon catheter is anticipated to witness significant growth during the forecast period 2021-2030? * How is the global advanced balloon catheter market anticipated to grow in the emerging economies, such as Asia-Pacific, Latin America, Middle East, and Africa?Key Topics Covered: 1 Product Definition2 Scope of Report3 Research Methodology4 Impact of COVID-19 on Global Advanced Balloon Catheter Market 4.1 Impact on Patients 4.2 Impact on Adoption Rate of Advanced Balloon Catheters 4.3 Impact on the Growth Rate of the Global Advanced Balloon Catheter Market 4.4 Entry Barriers and Opportunities for Companies Entering Global Advanced Balloon Catheter Market5 Epidemiology and Reimbursement Landscape for Global Advanced Balloon Catheter Market 5.1 Utilization of Balloon Catheters 5.1.1 Coronary Procedures 5.1.2 Peripheral Procedures 5.2 Reimbursement Landscape 5.2.1 The U.S. 5.2.2 Europe6 Industry Analysis 6.1 Industry Structure 6.1.1 Balloon Catheters Manufacturers 6.1.2 Distributors 6.2 Industry Supply Chain Analysis 6.2.1 Raw Material 6.2.2 Impact of COVID-19 on Supply Chain 6.3 Associations and Consortiums 6.4 Regulatory Framework 6.4.1 Regulatory Framework in North America 6.4.1.1 Food and Drug Administration (FDA) 6.4.1.2 Health Canada 6.4.2 Regulatory Framework in Europe 6.4.3 Regulatory Framework in Asia-Pacific 6.4.3.1 National Medical Products Administration (NMPA) 6.4.3.2 Pharmaceutical and Medical Device Agency (PMDA) 6.4.3.3 Central Drug Standard Control Organization (CDSCO) 6.5 Patent Analysis 6.5.1 Patent Analysis (by Product) 6.5.2 Patent Analysis (by Country)7 Competitive Landscape 7.1 Market Share Analysis 7.2 Key Developments and Strategies 7.2.1 Regulatory and Legal 7.2.2 Mergers and Acquisitions 7.2.3 Partnerships, Alliances, and Business Expansions 7.2.4 New Offerings 7.2.5 Funding Activities 7.3 Product Pipeline Analysis 7.4 Comparison Between Conventional Balloon Catheters and Advanced Balloon Catheters 7.5 Pricing Analysis8 Global Advanced Balloon Catheter Market Sizing and Forecast 8.1 Assumptions and Limitations 8.2 Key Findings and Opportunity Assessment 8.2.1 Key Findings 8.2.2 Opportunity Assessment 8.3 Market Dynamics 8.3.1 Market Drivers 8.3.1.1 Increasing Prevalence of Cardiovascular and Peripheral Artery Diseases 8.3.1.2 Increasing Demand for Minimally Invasive Surgeries 8.3.1.3 Advancements in Balloon Catheters 8.3.1.4 Favorable Reimbursement Landscape in Developed Economies 8.3.2 Market Restraints 8.3.2.1 Risk and Complications Associated with Catherization Procedures 8.3.2.2 High Cost of Angioplasty Procedures 8.3.3 Impact Analysis 8.3.4 Market Opportunities 8.3.4.1 Development of Novel Drug-Coated Balloon Catheters 8.3.4.2 Development of Multipurpose Advanced Balloon Catheter9 Global Advanced Balloon Catheter Market (by Product Type) 9.1 Overview 9.2 Normal Balloon Catheter 9.3 Cutting and Scoring Balloon Catheter 9.4 Drug-Coated Balloon Catheter 9.5 Stent Graft Balloon Catheter10 Global Advanced Balloon Catheter Market (by Application) 10.1 Overview 10.2 Coronary Procedures 10.3 Peripheral Procedures 10.4 Neurovascular Procedures 10.5 Other Procedures11 Global Advanced Balloon Catheter Market (by Component) 11.1 Overview 11.2 Rapid Exchange (Rx) Balloon Catheter 11.3 Over the Wire (OTW) Balloon Catheter 11.4 Fixed Wire Balloon Catheter12 Global Advanced Balloon Catheter Market (by Patient Age) 12.1 Overview 12.2 Adult 12.3 Pediatric13 Global Advanced Balloon Catheter Market (by End User) 13.1 Overview 13.2 Hospitals and Ambulatory Surgery Centers 13.3 Catheterization Laboratories 13.4 Others14 Global Advanced Balloon Catheter Market (by Region)15 Company Profiles 15.1 Company Overview 15.2 Role of Abbott Laboratories in Global Advanced Balloon Catheter Market 15.3 Financials 15.4 Recent Developments 15.5 SWOT Analysis * Abbott Laboratories * B. Braun Melsungen AG * Becton Dickinson and Company * Biotronik AG * Boston Scientific Corporation * Cardinal Health, Inc. * Cardionovum GmbH * Concept Medical Inc. * Cook Group * Hexacath * Koninklijke Philips N.V. * Medtronic plc * MicroPort Scientific Corporation * OrbusNeich Medical * Terumo CorporationFor more information about this report visit https://www.researchandmarkets.com/r/4h1axf Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
TORONTO – Restaurant Brands International Inc. reported net income of US$357 million for its third quarter, down from US$364 million in the same quarter last year.
The company, which keeps its books in U.S. dollars, says its profit amounted to 79 cents US per diluted share for the quarter ended Sept. 30 compared with 79 cents US per diluted share a year earlier.
Revenue for the parent company of Tim Hortons, Burger King, Popeyes and Firehouse Subs, totalled US$2.29 billion, up from US$1.84 billion in the same quarter last year.
Consolidated comparable sales were up 0.3 per cent.
On an adjusted basis, Restaurant Brands says it earned 93 cents US per diluted share in its latest quarter, up from an adjusted profit of 90 cents US per diluted share a year earlier.
The average analyst estimate had been for a profit of 95 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
ST. JOHN’S, N.L. – Fortis Inc. reported a third-quarter profit of $420 million, up from $394 million in the same quarter last year.
The electric and gas utility says the profit amounted to 85 cents per share for the quarter ended Sept. 30, up from 81 cents per share a year earlier.
Fortis says the increase was driven by rate base growth across its utilities, and strong earnings in Arizona largely reflecting new customer rates at Tucson Electric Power.
Revenue in the quarter totalled $2.77 billion, up from $2.72 billion in the same quarter last year.
On an adjusted basis, Fortis says it earned 85 cents per share in its latest quarter, up from an adjusted profit of 84 cents per share in the third quarter of 2023.
The average analyst estimate had been for a profit of 82 cents per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
TORONTO – Thomson Reuters reported its third-quarter profit fell compared with a year ago as its revenue rose eight per cent.
The company, which keeps its books in U.S. dollars, says it earned US$301 million or 67 cents US per diluted share for the quarter ended Sept. 30. The result compared with a profit of US$367 million or 80 cents US per diluted share in the same quarter a year earlier.
Revenue for the quarter totalled US$1.72 billion, up from US$1.59 billion a year earlier.
In its outlook, Thomson Reuters says it now expects organic revenue growth of 7.0 per cent for its full year, up from earlier expectations for growth of 6.5 per cent.
On an adjusted basis, Thomson Reuters says it earned 80 cents US per share in its latest quarter, down from an adjusted profit of 82 cents US per share in the same quarter last year.
The average analyst estimate had been for a profit of 76 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
